NVAX - Financial Reports List - Novavax, Inc. - IntrinsicAlpha

Novavax, Inc. NVAX

Healthcare - Biotechnology - NASDAQ - US

$ 6.175

0.167 %

$ 993 M

Market Cap

-4.89

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-69.69%	54.58%	28.59%
Annual Report	FY	10-K	2024-12-31	22.61%	65.60%	56.06%
Quarterly Report	Q3	8-K	2024-09-30	283.03%	7.25%	-6.68%
Quarterly Report	Q2	8-K	2024-06-30	-2.11%	179.93%	190.31%
Quarterly Report	Q1	8-K	2024-03-31	15.94%	49.80%	55.64%
Quarterly Report	Q4	8-K	2023-12-31	1.22%	2.12%	24.73%
Annual Report	FY	10-K	2023-12-31	-65.20%	17.16%	12.13%
Quarterly Report	Q3	8-K	2023-09-30	-97.00%	22.44%	1.22%
Quarterly Report	Q2	8-K	2023-06-30	128.28%	111.36%	111.48%
Quarterly Report	Q1	8-K	2023-03-31	-88.50%	-144.49%	-149.44%

1